Submitted by olivia-rzadkiewicz on Mon, 13/06/2016 - 16:52
The second Phase 3 clinical trial is to begin for ZX008, a branded version of low-dose fenfluramine, designed as an adjunctive treatment of seizures in children with Dravet syndrome.
Submitted by olivia-rzadkiewicz on Fri, 15/04/2016 - 15:19
A new preliminary study has found that an anti-epileptic drug that can be taken once a day to control seizures may work as effectively as a drug that must be taken twice a day.
Submitted by olivia-rzadkiewicz on Thu, 04/02/2016 - 16:05
Two separate studies have analysed the benefits and side-effects of two antiepileptic drugs, rufinamide and retigabine.